ACT for Syndromic and Subsyndromic Depression in Bipolar Disorder
NCT06365021
Bipolar Disorder, Bipolar and Related Disorders
São Paulo, Brazil
View Trial DetailsNCT Number: NCT01770704
The objective of the ambispective cohort study is to describe clinical management and clinical outcomes related to bipolar disorder in China, and establish the factors associated with different management patterns and clinical outcomes, provide psychiatrists with reliable and up-to-date information on the disease.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Research Site, Beijing, Beijing Municipality, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Up to 21 months
Time frame: Up to 21 months
Time frame: Up to 21 months
AstraZeneca
Industry
Chinese Observation Study of the Clinical Management of Bipolar Disorder
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06365021
Bipolar Disorder, Bipolar and Related Disorders
São Paulo, Brazil
View Trial DetailsNCT02481245
Bipolar Disorder, Bipolar and Related Disorders
Boston, Massachusetts, United States
View Trial DetailsNCT03336918
Behavior, Behavioral Symptoms
Cleveland, Ohio, United States
View Trial DetailsNCT04696471
Bipolar Disorder, Bipolar and Related Disorders
Pittsburgh, Pennsylvania, United States
View Trial Details